"Overview of Tumor Immunotherapy based on Indoleamine 2, 3 Dioxygenase ..."

Xiangyu Hao (2020)

> Home

Details and statistics

DOI: 10.1145/3444884.3444917

access: closed

type: Conference or Workshop Paper

metadata version: 2023-03-21

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - conf/icbbe/Hao20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/icbbe/Hao20
Xiangyu Hao:
Overview of Tumor Immunotherapy based on Indoleamine 2, 3 Dioxygenase Inhibitors. ICBBE 2020: 171-175

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.